Regarding the value of using dysadherin expression as a prognostic marker, differentiated and undifferentiated thyroid cancers perhaps are best analyzed separately because of their different behaviors, pathologies, and relative E-cadherin expression which may affect metastatic potential and prognostic utility [28, 38]. The gene discussed is FXYD5; the disease is thyroid gland carcinoma.